Berenberg Capital Markets
Mathieu Lane has over 25 years of work experience in the finance and healthcare sector. Mathieu began their career at Genzyme as a Senior Research Associate in Gene Therapy R&D. Mathieu then moved on to work at Bear Stearns & Co. as a Vice President. Following that, they joined SR One Capital Management as a Partner and Finance Director. Mathieu later transitioned to Guggenheim Securities Investment Banking, where they worked as a Managing Director for over a decade. Mathieu then joined eTheRNA immunotherapies as the Chief Financial Officer before ultimately becoming the Head of Healthcare Investment Banking at Berenberg Capital Markets in 2023.
From 1999 to 2001, Mathieu Lane attended NYU Stern School of Business, where they pursued a Master of Business Administration (MBA) degree with a specialization in Finance and Accounting.
Berenberg Capital Markets
1 followers
Berenberg Capital Markets LLC (BCM) is a FINRA-registered US-based broker-dealer; headquartered in New York, with branches in Boston, Chicago, and San Francisco. BCM is a wholly owned, independent subsidiary of Joh. Berenberg, Gossler & Co. KG (Berenberg), one of Europe’s leading privately-owned banks, established in 1590. Together BCM and Berenberg cover over 1,000 European and US equities, with a 120+ person research department based out of London and NYC. Building on its strength and expertise across multiple industries, BCM continues to rapidly expand the breadth of research, sales, trading, and Investment Banking services it offers, in order to assist its institutional and corporate clients’ access to the global equity markets. BCM adopts the same principles as its parent company and is committed to building long-term relationships with its clients based on high levels of accountability, responsibility, insight, vision and expertise.